Gall-Troselj K, Kusić B, Pećina-Slaus N, Pavelić K, Pavelić J
Division of Molecular Medicine, Ruder Bosković Institute, Zagreb, Croatia.
Eur J Clin Chem Clin Biochem. 1995 Oct;33(10):733-6. doi: 10.1515/cclm.1995.33.10.733.
Testing for the presence of hepatitis C virus (HCV) in blood derivatives used in clinical medicine is of enormous importance to ensure the production of safe preparations. So far, no system has been developed for the isolation and detection of hepatitis C virus from blood derivatives. The recently introduced commercial kit for the detection of hepatitis C virus is designed for the isolation and detection of virus from blood serum. A reliable and reproducible method for the isolation of hepatitis C virus RNA, subsequent reverse transcription and nested polymerase chain reaction (PCR) from blood derivatives is described. Of 17 batches of factor VIII, gamma-globulin and anti tetanus, cytomegalovirus and Varicella-zoster immunoglobulin concentrates, respectively (14 negative for anti HCV and 3 of unknown anti HCV status) five were found positive in RNA-PCR.
检测临床医学中使用的血液制品中丙型肝炎病毒(HCV)的存在对于确保安全制剂的生产极为重要。到目前为止,尚未开发出从血液制品中分离和检测丙型肝炎病毒的系统。最近推出的用于检测丙型肝炎病毒的商业试剂盒是设计用于从血清中分离和检测病毒的。本文描述了一种可靠且可重复的方法,用于从血液制品中分离丙型肝炎病毒RNA,随后进行逆转录和巢式聚合酶链反应(PCR)。在分别为17批的凝血因子VIII、γ-球蛋白、抗破伤风、巨细胞病毒和水痘-带状疱疹免疫球蛋白浓缩物中(14批抗HCV阴性,3批抗HCV状态未知),有5批在RNA-PCR检测中呈阳性。